http://www.savarapharma.com
Savara Inc. Company Intro
Clinical Studies Savara is working to initiate a second Phase 3 clinical study of Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP) and expects to speak with the… read more ?
Industry
Healthcare
Savara Inc. Headquaters
Building 3
Austin,78746
United States
Savara Inc. Share price
17 May 2023 13:57 GMT
$2.1600
0.0 (0.0 %)
Savara Inc. Market cap
$249.805 M
WMC RANKING
2023
Savara Inc. # 299
BiotechnologyLatest Savara Inc. News
28 May 2023
David A. Ramsay Acquires 50000 Shares of Savara Inc ...
Savara Inc, formerly Mast Therapeutics, Inc, is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of...
27 May 2023
Targeted Drug Delivery System Industry, Share, Growth ...
... Rexahn Pharmaceuticals Inc, Roche Holding AG, Savara Inc, Serina Therapeutics Inc., Silenseed Ltd., SoluBest Ltd, Suda Ltd, Taiwan Liposome Co.
25 May 2023
Savara Inc. (SVRA)'s liquidity ratios and what they mean
The price of Savara Inc. (NASDAQ: SVRA) closed at $2.60 in the last session, up 1.96% from day before closing price of $2.55. On the day, 538700 shares were...
WMC Market Score
WMC Market to Revenue Score
Savara Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Savara Inc. | USD | $257 | $42,812 | $-44,411 | $2,498M | 299 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Savara Inc. Social Followers vs Top 4 Industry Competitors
Savara Inc. Post vs Top 4 Industry Competitors
Savara Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Savara Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Savara Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Savara Inc. | 0.00 | 0.31 | 0.00 | 0 | 0 | 0 | 0.14 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
